Genmab Reaches Fifth Milestone in Ofatumumab Collaboration
COPENHAGEN, August 21 /PRNewswire/ --
- Summary: Genmab Will Receive a Milestone Payment of Approximately DKK 232.7 Million From GSK for Achievement of Positive Results in the Phase III CLL Study.…